LPL Financial
CMPX icon

LPL Financial’s Compass Therapeutics CMPX Stock Holding History

LPL Financial’s Portfolio CMPX Stock Details CMPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$188K Sell
35,470
-9,000
-20% -$51.9K ﹤0.01% 5523
2025
Q4 		$239K Buy
44,470
+2,000
+5% +$9.23K ﹤0.01% 5328
2025
Q3 		$149K Hold
42,470
– – ﹤0.01% 5425
2025
Q2 		$110K Buy
42,470
+370
+0.9% +$763 ﹤0.01% 5248
2025
Q1 		$80K Sell
42,100
-2,900
-6% -$7.71K ﹤0.01% 5082
2024
Q4 		$65.3K Sell
45,000
-5,000
-10% -$8.3K ﹤0.01% 5073
2024
Q3 		$92K Hold
50,000
– – ﹤0.01% 4910
2024
Q2 		$50K Buy
+50,000
New +$73K ﹤0.01% 4837

Other funds holding CMPX

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

LPL Financial's CMPX Position: Q1 2026 in Review

LPL Financial reduced its Compass Therapeutics (CMPX) stake by 20% in Q1 2026, selling an estimated $51.9K and leaving 35,470 shares worth $188K. The position accounts for ﹤0.01% of the portfolio, ranked #5523.

LPL Financial first reported a position in CMPX in Q2 2024 and has held it in 8 quarters since. The position peaked at $239K in Q4 2025. 201 funds tracked by Wall St. Rank hold CMPX as of Q1 2026.

  • LPL Financial held 35,470 shares of Compass Therapeutics worth $188K as of Q1 2026.
  • LPL Financial sold 9,000 Compass Therapeutics shares in Q1 2026, an estimated $51.9K.
  • Compass Therapeutics made up ﹤0.01% of LPL Financial's portfolio in Q1 2026, its #5523 holding.
  • LPL Financial first reported a position in Compass Therapeutics in Q2 2024 and has held it in 8 quarters since.
  • LPL Financial's Compass Therapeutics position peaked at $239K in Q4 2025.
  • 201 funds tracked by Wall St. Rank held Compass Therapeutics as of Q1 2026.

Based on LPL Financial's 13F filing for Q1 2026, filed 6 May 2026.